Unlikely to cause harm — often a labeling or packaging issue.
Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.
| Brand name | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Generic name | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Active ingredient(s) | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Distributed by / for | Hikma Pharmaceuticals USA Inc. |
| NDC | 0143-9850-01 |
| Full product label | methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by: HIKMA FARMACEUTICA (PORTUGAL), SA; Dist by: WEST-WARD, Eatontown, NJ 07724, NDC 0143-9850-01. |
| Recalling firm | Hikma Pharmaceuticals USA Inc. |
| Distribution | Nationwide in the USA |
| Quantity | 4840 vials |
| Recall initiated | 2020-01-14 |
| Report date | 2020-01-29 |
| Recall completed | 2021-09-08 |
| Recall number | D-0801-2020 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Cherry Hill NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗